| Kelly A Hoover, | |
|
501 Valley View Blvd, Altoona, PA 16602-1749 | |
| (814) 944-5014 | |
| (914) 944-6500 |
| Full Name | Kelly A Hoover |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 501 Valley View Blvd, Altoona, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316124266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL007571 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly A Hoover, 501 Valley View Blvd, Altoona, PA 16602-1749 Ph: (814) 944-5014 | Kelly A Hoover, 501 Valley View Blvd, Altoona, PA 16602-1749 Ph: (814) 944-5014 |
News Archive
Medtronic, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for the Aquamantys® SBS 5.0 Sheathed Bipolar Sealer, a new addition to the spine portfolio of the company's Advanced Energy business.
A team of cardiac experts led by Dr. N S Devananda, Consultant Cardiac Surgeon, Wockhardt Hospitals, Bangalore (Now a Network Hospital of Fortis) has performed a major open heart surgery on a 2-year-old baby from Nigeria. Baby Brendan was suffering from congenital heart defect called - Tetralogy of Fallot or complex blue baby syndrome.
Obese adolescents are significantly more likely to report musculoskeletal pain than their nonobese counterparts, researchers report.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 2b study designed to evaluate the efficacy and safety of MP4OX treatment plus standard of care in severely injured trauma patients with lactic acidosis due to hemorrhagic shock.
AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, announces the publication of results from the human phase 2 study of masitinib carried-out in the treatment of progressive multiple sclerosis.
› Verified 1 days ago
Aimee Lynn Dantos, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Valley View Blvd, Altoona, PA 16602 Phone: 814-944-5014 | |
Diane K Ringler, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 Chestnut Ave, Altoona, PA 16601 Phone: 814-944-8177 Fax: 814-944-7413 | |
Mrs. Janet Kay Pennington, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Valley View Blvd, Altoona, PA 16602 Phone: 814-944-5014 Fax: 814-944-6500 | |
Christina L Weaver, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Valley View Blvd, Altoona, PA 16602 Phone: 814-944-5014 Fax: 814-944-6500 | |
Kylie Cappella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Valley View Blvd, Altoona, PA 16602 Phone: 814-205-1404 Fax: 814-201-2021 | |
Pamela Jan Grozanick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 Sheraton Dr, Altoona, PA 16601 Phone: 814-949-2050 Fax: 814-949-2051 | |
Mrs. Rebecca S Burns, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 877 42nd St, Altoona, PA 16601 Phone: 000-000-0000 |